Co-inhibitory signals. (A) CTLA-4 signal may inhibit T cells through... | Download Scientific Diagram
Dr. Prenek Lilla
Molecules | Free Full-Text | Development of CDK4/6 Inhibitors: A Five Years Update
A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding | PNAS
Mechanism of action of CTLA-4 checkpoint inhibitor. CTLA-4 and CD28 are... | Download Scientific Diagram
CD40 agonist-induced IL-12p40 potentiates hepatotoxicity | Journal for ImmunoTherapy of Cancer
Intrinsic and acquired resistance to CDK4/6 inhibitors and potential overcoming strategies | Acta Pharmacologica Sinica
PROactively TACkling CDK4/6 therapy resistance | Nature Cancer
Myeloid immune-checkpoint inhibition enters the clinical stage | Nature Reviews Clinical Oncology
Small molecule CDK4/6 inhibitors inhibit cell cycle progression by... | Download Scientific Diagram
Discovery of novel CDK inhibitors via scaffold hopping from CAN508 - ScienceDirect
dc_2020_22
Mechanisms of therapeutic CDK4/6 inhibition in breast cancer - ScienceDirect
Inhibition of G1/S cyclin-dependent kinases by CDK4/6 inhibitors. A The... | Download Scientific Diagram
The Use of Post-attachment Inhibitors for HIV Treatment
Senescence as a therapeutically relevant response to CDK4/6 inhibitors | Oncogene
Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19 | SpringerLink
Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice - ScienceDirect
Dr. Prenek Lilla
Mechanisms of the CDK4/6 inhibitor palbociclib (PD 0332991) and its future application in cancer treatment (Review)
Novel Therapeutic Strategies for CDK4/6 Inhibitors in Metastatic Castr | OTT
The combination of CDK4/6 inhibitor and PD-1/PD-L1 immune checkpoint blocker is expected to enhance treatment efficacy
Overview of CDK4/6 and MAPK inhibitors. (a) FDA approved small-molecule... | Download Scientific Diagram
